Quarterly report pursuant to Section 13 or 15(d)

4. Commitments and Contingencies (Narrative)

v2.4.0.8
4. Commitments and Contingencies (Narrative) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Mar. 31, 2013
Potential severance under certain employment agreements $ 1,843   $ 1,843    
Aggregated annual salaries under certain employment agreements 1,310   1,310    
Product revenue 3,456 3,890 6,177 7,674  
Innovacyn
         
Accounts receivable 801   801   264
Product revenue 1,289 1,229 2,030 2,365  
More Pharma
         
Accounts receivable 717   717   580
Product revenue $ 378 $ 183 $ 752 $ 183